Compare · ATEC vs GMED
ATEC vs GMED
Side-by-side comparison of Alphatec Holdings Inc. (ATEC) and Globus Medical Inc. (GMED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATEC and GMED operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- GMED is the larger of the two at $11.18B, about 7.8x ATEC ($1.44B).
- Over the past year, ATEC is down 39.3% and GMED is up 38.5% - GMED leads by 77.8 points.
- ATEC has been more active in the news (8 items in the past 4 weeks vs 5 for GMED).
- GMED has more recent analyst coverage (25 ratings vs 20 for ATEC).
- Company
- Alphatec Holdings Inc.
- Globus Medical Inc.
- Price
- $9.30+0.98%
- $82.34+1.49%
- Market cap
- $1.44B
- $11.18B
- 1M return
- -2.11%
- +7.42%
- 1Y return
- -39.30%
- +38.50%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2006
- 2012
- News (4w)
- 8
- 5
- Recent ratings
- 20
- 25
Alphatec Holdings Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.
Globus Medical Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Latest ATEC
- GENERAL COUNSEL & CORP. SEC. Marshall Tyson Eliot sold $78,821 worth of shares (8,168 units at $9.65) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 630,398 units (SEC Form 4) (for tax liability)
- SEC Form 10-Q filed by Alphatec Holdings Inc.
- SEC Form S-8 filed by Alphatec Holdings Inc.
- Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ATEC Reports Second Quarter Financial Results
- UBS initiated coverage on Alphatec with a new price target
- ATEC Announces Participation in Upcoming Investor Conferences
- Stephens initiated coverage on Alphatec with a new price target
- ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026
- BMO Capital Markets initiated coverage on Alphatec with a new price target
Latest GMED
- SEC Form 10-Q filed by Globus Medical Inc.
- Globus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Globus Medical Reports Second Quarter 2026 Results
- Director Davidar David D gifted 2,500 shares, decreasing direct ownership by 0.49% to 507,675 units (SEC Form 4)
- UBS initiated coverage on Globus Medical with a new price target
- Globus Medical Schedules Second Quarter Earnings Release and Conference Call
- BMO Capital Markets initiated coverage on Globus Medical with a new price target
- Director Davidar David D exercised 25,000 shares at a strike of $26.27 and sold $2,019,072 worth of shares (25,000 units at $80.76) (SEC Form 4)
- Director Rhoads Ann D exercised 25,000 shares at a strike of $26.27, increasing direct ownership by 163% to 40,384 units (SEC Form 4)
- Globus Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits